These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 16177380

  • 1. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
    Baldwin MR, Tepp WH, Pier CL, Bradshaw M, Ho M, Wilson BA, Fritz RB, Johnson EA, Barbieri JT.
    Infect Immun; 2005 Oct; 73(10):6998-7005. PubMed ID: 16177380
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
    Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, Laporte SL, Tepp WH, Bradshaw M, Johnson EA, Smith LA, Marks JD.
    Infect Immun; 2005 Sep; 73(9):5450-7. PubMed ID: 16113261
    [Abstract] [Full Text] [Related]

  • 6. Subunit vaccine against the seven serotypes of botulism.
    Baldwin MR, Tepp WH, Przedpelski A, Pier CL, Bradshaw M, Johnson EA, Barbieri JT.
    Infect Immun; 2008 Mar; 76(3):1314-8. PubMed ID: 18070903
    [Abstract] [Full Text] [Related]

  • 7. Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B).
    Shearer JD, Vassar ML, Swiderski W, Metcalfe K, Niemuth N, Henderson I.
    Vaccine; 2010 Oct 21; 28(45):7313-8. PubMed ID: 20816903
    [Abstract] [Full Text] [Related]

  • 8. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
    Atassi MZ, Jankovic J, Steward LE, Aoki KR, Dolimbek BZ.
    Immunobiology; 2012 Jan 21; 217(1):17-27. PubMed ID: 21962573
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
    Sahay B, Colliou N, Zadeh M, Ge Y, Gong M, Owen JL, Valletti M, Jobin C, Mohamadzadeh M.
    Vaccine; 2018 Jan 02; 36(1):155-164. PubMed ID: 29180028
    [Abstract] [Full Text] [Related]

  • 12. Enhancing the protective immune response against botulism.
    Przedpelski A, Tepp WH, Kroken AR, Fu Z, Kim JJ, Johnson EA, Barbieri JT.
    Infect Immun; 2013 Jul 02; 81(7):2638-44. PubMed ID: 23670557
    [Abstract] [Full Text] [Related]

  • 13. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S, Ponmariappan S, Sharma A, Kamboj DV, Jain AK.
    Protein Pept Lett; 2017 Jul 02; 24(6):495-502. PubMed ID: 28260503
    [Abstract] [Full Text] [Related]

  • 14. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
    Yu Y, Shi D, Liu S, Gong ZW, Wang S, Sun Z.
    Hum Vaccin Immunother; 2015 Jul 02; 11(2):468-73. PubMed ID: 25483668
    [Abstract] [Full Text] [Related]

  • 15. Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain.
    Avril A, Miethe S, Popoff MR, Mazuet C, Chahboun S, Rasetti-Escargueil C, Sesardic D, Thullier P, Hust M, Pelat T.
    BMC Biotechnol; 2015 Sep 17; 15():86. PubMed ID: 26382731
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bivalent recombinant vaccine for botulinum neurotoxin types A and B based on a polypeptide comprising their effector and translocation domains that is protective against the predominant A and B subtypes.
    Shone C, Agostini H, Clancy J, Gu M, Yang HH, Chu Y, Johnson V, Taal M, McGlashan J, Brehm J, Tong X.
    Infect Immun; 2009 Jul 17; 77(7):2795-801. PubMed ID: 19398544
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.